ArticleACS omega2026
Preclinical Evaluation of Colisorb: Surfactant-Free Hydrophilic Gelatin Sponge with Rapid Clotting and Enhanced Absorbency without Mechanical Compression.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development of Dual-Cross-Linked AlgMA/HAMA Hybrid Hydrogels for Traumatic Wound Healing.ACS omega · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rapid hemostasis is a major challenge in surgery, especially for noncompressible wounds such as liver wounds. Conventional hemostatic products often fall short of achieving the desired level of hemostasis. The current study introduces Colisorb, a novel cross-linked gelatin-based sponge for controlling surgical bleeding. The Colisorb sponge is a superabsorbent, adhesive, biocompatible, biodegradable, mechanically stable gelatin-based sponge with superior swelling kinetics, which allows strong swelling capability up to 70× its weight, thus indicating strong capability for blood absorption. Electron microscopic examination shows that the sponge has an interconnected network structure with pore sizes of 100 to 300 μm. Colisorb sponge also exhibits higher porosity and tensile strength compared to commercial products. Additionally, the Colisorb sponge demonstrated rapid degradation in only 3 days.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.